Manish Monga

Title: Manish Monga: Innovator in Cancer Therapy

Introduction

Manish Monga is a notable inventor based in Wheeling, West Virginia. He has made significant contributions to the field of cancer therapy, particularly in the treatment of lung cancer. His innovative approaches aim to improve patient outcomes through precise detection methods.

Latest Patents

Manish Monga holds a patent titled "Quantifying FR-α and GART proteins for optimal cancer therapy." This patent outlines improved methods for treating cancer patients, specifically those suffering from lung cancer. The methods involve identifying whether a lung tumor will respond to a therapeutic regimen that includes pemetrexed and optionally cisplatin. By utilizing SRM-mass spectrometry, specific FR-α fragment peptides and GART fragment peptides are detected and quantified directly in lung tumor cells. This process allows for a comparison to reference levels, determining the likelihood of a positive response to treatment.

Career Highlights

Throughout his career, Manish Monga has worked with reputable organizations, including Expression Pathology Incorporated and West Virginia University. His work has focused on advancing cancer treatment methodologies and enhancing the precision of therapeutic approaches.

Collaborations

Manish has collaborated with esteemed colleagues such as Todd Hembrough and Fabiola Cecchi. These partnerships have contributed to the development of innovative solutions in cancer therapy.

Conclusion

Manish Monga's contributions to cancer therapy through his patent and collaborative efforts highlight his commitment to improving patient care. His work exemplifies the impact of innovation in the medical field, particularly in the fight against lung cancer.